These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1531403)

  • 1. Erythematous, hemorrhagic, and necrotic plaques in an elderly man. Coumarin-induced skin necrosis.
    Sharafuddin MJ; Sanaknaki BA; Kibbi AG
    Arch Dermatol; 1992 Jan; 128(1):105, 108. PubMed ID: 1531403
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sintrom-induced cutaneous necrosis; a little-known complication].
    Núñez L; Córcoles JL; Romero A; Guedes P; Amorós C; Morillas P
    Arch Cardiol Mex; 2018; 88(1):76-77. PubMed ID: 28864238
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocytoclastic vasculitis: another coumarin-induced hemorrhagic reaction.
    Tamir A; Wolf R; Brenner S
    Acta Derm Venereol; 1994 Mar; 74(2):138-9. PubMed ID: 7911622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent erythema annulare centrifugum during ustekinumab treatment in a psoriatic patient.
    Chou WT; Tsai TF
    Acta Derm Venereol; 2013 Mar; 93(2):208-9. PubMed ID: 22983014
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous necrosis and multinucleate epidermal cells associated with intravenous phenytoin.
    Hunt SJ
    Am J Dermatopathol; 1995 Aug; 17(4):399-402. PubMed ID: 8600807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case of cetuximab-induced disseminated necrotic and maculopapular eruptions: Involvement of an epidermal growth factor receptor inhibitor with epidermal necrosis.
    Namiki T; Omigawa C; Nojima K; Wakasa T; Tokoro S; Hanafusa T; Miura K; Yokozeki H
    J Dermatol; 2018 Jan; 45(1):e3-e4. PubMed ID: 28971521
    [No Abstract]   [Full Text] [Related]  

  • 7. Possibly drug-induced palpable migratory arciform erythema.
    Dantas FL; Valente NY; Veronez IS; Kakizaki P; Leitão JR; Fraga RC
    An Bras Dermatol; 2015; 90(3 Suppl 1):77-80. PubMed ID: 26312680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent docetaxel-induced supravenous erythematous eruption.
    Fernandes Kde A; Felix PA
    An Bras Dermatol; 2015; 90(5):728-30. PubMed ID: 26560218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythematous-to-brownish plaques on the upper back: a quiz. Phenytoin-induced T-cell predominant pseudolymphoma (“pseudomycosis fungoides”) with T-cell clonality.
    Toberer F; Hartschuh W; Kutzner H; Flux K
    Acta Derm Venereol; 2015 Mar; 95(3):378-82. PubMed ID: 25111894
    [No Abstract]   [Full Text] [Related]  

  • 10. BRAF Inhibitor-Induced Antitumoral Granulomatous Dermatitis Eruption in Advanced Melanoma.
    Garrido MC; Gutierrez C; Riveiro-Falkenbach E; Ortiz P; Rodriguez-Peralto JL
    Am J Dermatopathol; 2015 Oct; 37(10):795-8. PubMed ID: 26381028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-pigmenting fixed drug eruption induced by sorafenib.
    Tanabe K; Amoh Y; Mii S; Eto H; Iwamura M; Katsuoka K
    Acta Derm Venereol; 2010 May; 90(3):307. PubMed ID: 20526556
    [No Abstract]   [Full Text] [Related]  

  • 12. Generalized fixed drug eruption caused by pazufloxacin.
    Sawada Y; Nakamura M; Tokura Y
    Acta Derm Venereol; 2011 Sep; 91(5):600-1. PubMed ID: 21597677
    [No Abstract]   [Full Text] [Related]  

  • 13. Fixed drug eruption (phenolphthalein). Evidence for a blood-borne mediator.
    Wyatt E; Greaves M; Sondergaard J
    Arch Dermatol; 1972 Nov; 106(5):671-3. PubMed ID: 4117910
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent supravenous erythematous eruption: a rare local complication of intravenous 5-fluorouracil therapy.
    Pujol RM; Rocamora V; Lopez-Pousa A; Taberner R; Alomar A
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):839-42. PubMed ID: 9810911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eczema-like, erythematous, infiltrated plaques: a common side effect of subcutaneous heparin therapy.
    Klein GF; Kofler H; Wolf H; Fritsch PO
    J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):703-7. PubMed ID: 2530252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etizolam-induced superficial erythema annulare centrifugum.
    Kuroda K; Yabunami H; Hisanaga Y
    Clin Exp Dermatol; 2002 Jan; 27(1):34-6. PubMed ID: 11952667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symmetric ptychotropic and nonpigmenting fixed drug eruption due to cimetidine (so-called baboon syndrome).
    Helmbold P; Hegemann B; Dickert C; Marsch WC
    Dermatology; 1998; 197(4):402-3. PubMed ID: 9873190
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect.
    Garcovich S; Burlando M; Rongioletti F; Garcovich A; Parodi A; Amerio P
    Acta Derm Venereol; 2010 May; 90(3):311-2. PubMed ID: 20526559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Secondary drug toxiderma to acenocoumarol].
    Khammassi N; Kessentini N
    Pan Afr Med J; 2015; 22():95. PubMed ID: 26848342
    [No Abstract]   [Full Text] [Related]  

  • 20. Is cetuximab-induced rash conclusion really a remnant of the skin erythema dose?
    Oskan F; Belka C; Manapov F
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):462-3. PubMed ID: 24074919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.